:: Volume 11, Issue 3 (Int J Mol Cell Med 2022) ::
Int J Mol Cell Med 2022, 11(3): 197-206 Back to browse issues page
Vitexin Induces Apoptosis in MCF-7 Breast Cancer Cells through the Regulation of Specific miRNAs Expression
Reza Najafipour1 , Abdolmabood Momeni2 , Yoosef Mirmazloomi3 , Sahar Moghbelinejad 4
1- Genetics Research Center, the University of Social Welfare and Rehabilitation Science, Tehran, Iran.
2- Khatam pathobiology and genetics lab, Qazvin, Iran.
3- School of Medicine, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Iran.
4- Research Institute for Prevention of Non-Communicable Diseases, Cellular and Molecular Research Centre, Qazvin University of Medical Sciences, Shahid Bahonar Boulevard, Qazvin, Iran. , smoghbelinejad@qums.ac.ir
Abstract:   (1308 Views)

In this research, we investigated microRNAs (miRNAs) expression profile in MCF-7 breast cancer cell line which treated with 150 µM vitexine. Profiling of miRNAs expression was performed using TaqMan MiRNA Array. Apoptosis was analyzed by flow cytometry and the expression of some genes involved in "anti-proliferative" signaling pathways were evaluated by western blotting and real time PCR methods. Twenty microRNAs were differentially expressed in vitexine treated cells compared to the control. Among them, let-7-b,c  were up regulated while miRNA-17-5p was down regulated with highest score. Also, we detected the expression changes of mentioned miRNAs target genes as well as genes involved in caspase apoptosis pathways. Our results provide the first evidence that vitexin can effect miRNA expression in MCF-7 cells. Also based on our finding, vitexin can be an attractive miRNA mediated chemo preventive and therapeutic agent in breast cancer.

Keywords: Vitexin, MicroRNA, breast cancer, apoptosis
Full-Text [PDF 551 kb]   (821 Downloads)    
Type of Study: Original Article | Subject: Cancer
Received: 2022/09/7 | Accepted: 2023/07/9 | Published: 2023/07/9



XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (Int J Mol Cell Med 2022) Back to browse issues page